OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C
Caleb C. Lord, Steven C. Wyler, Rong Wan, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 9, pp. 3402-3406
Open Access | Times Cited: 146
Caleb C. Lord, Steven C. Wyler, Rong Wan, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 9, pp. 3402-3406
Open Access | Times Cited: 146
Showing 1-25 of 146 citing articles:
Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
Stephen Kaar, Sridhar Natesan, Robert A. McCutcheon, et al.
Neuropharmacology (2019) Vol. 172, pp. 107704-107704
Closed Access | Times Cited: 283
Stephen Kaar, Sridhar Natesan, Robert A. McCutcheon, et al.
Neuropharmacology (2019) Vol. 172, pp. 107704-107704
Closed Access | Times Cited: 283
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 163
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 163
Association Between Antipsychotic Medication Use and Diabetes
R. I. G. Holt
Current Diabetes Reports (2019) Vol. 19, Iss. 10
Open Access | Times Cited: 131
R. I. G. Holt
Current Diabetes Reports (2019) Vol. 19, Iss. 10
Open Access | Times Cited: 131
Centrally Acting Agents for Obesity: Past, Present, and Future
Ann A. Coulter, Candida J. Rebello, Frank L. Greenway
Drugs (2018) Vol. 78, Iss. 11, pp. 1113-1132
Open Access | Times Cited: 121
Ann A. Coulter, Candida J. Rebello, Frank L. Greenway
Drugs (2018) Vol. 78, Iss. 11, pp. 1113-1132
Open Access | Times Cited: 121
The Novel Perspectives of Adipokines on Brain Health
Thomas H. Lee, Kenneth K.Y. Cheng, Ruby L.C. Hoo, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5638-5638
Open Access | Times Cited: 81
Thomas H. Lee, Kenneth K.Y. Cheng, Ruby L.C. Hoo, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5638-5638
Open Access | Times Cited: 81
Photobiomodulation Therapy and the Glymphatic System: Promising Applications for Augmenting the Brain Lymphatic Drainage System
Farzad Salehpour, Mahsa Khademi, Denis E. Bragin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2975-2975
Open Access | Times Cited: 55
Farzad Salehpour, Mahsa Khademi, Denis E. Bragin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2975-2975
Open Access | Times Cited: 55
Diabetes and Mental Health
David J. Robinson, Kimberley Hanson, Akshay Jain, et al.
Canadian Journal of Diabetes (2023) Vol. 47, Iss. 4, pp. 308-344
Open Access | Times Cited: 36
David J. Robinson, Kimberley Hanson, Akshay Jain, et al.
Canadian Journal of Diabetes (2023) Vol. 47, Iss. 4, pp. 308-344
Open Access | Times Cited: 36
GLP-2 prevents antipsychotics-induced metabolic dysfunction in mice
Yanmin Peng, Chenzhang Feng, Shiyu Peng, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 1
Yanmin Peng, Chenzhang Feng, Shiyu Peng, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 1
Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes
Jiezhong Chen, Xu‐Feng Huang, Renfu Shao, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 77
Jiezhong Chen, Xu‐Feng Huang, Renfu Shao, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 77
Antipsychotics-induced metabolic alterations: Recounting the mechanistic insights, therapeutic targets and pharmacological alternatives
Raghunath Singh, Yashika Bansal, Bikash Medhi, et al.
European Journal of Pharmacology (2018) Vol. 844, pp. 231-240
Closed Access | Times Cited: 69
Raghunath Singh, Yashika Bansal, Bikash Medhi, et al.
European Journal of Pharmacology (2018) Vol. 844, pp. 231-240
Closed Access | Times Cited: 69
Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics
Simona Cernea, Lorena Dima, Christoph U. Correll, et al.
Drugs (2020) Vol. 80, Iss. 17, pp. 1763-1781
Closed Access | Times Cited: 54
Simona Cernea, Lorena Dima, Christoph U. Correll, et al.
Drugs (2020) Vol. 80, Iss. 17, pp. 1763-1781
Closed Access | Times Cited: 54
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia
Nicholas A Keks, Judy Hope, Darren Schwartz, et al.
CNS Drugs (2020) Vol. 34, Iss. 5, pp. 473-507
Closed Access | Times Cited: 51
Nicholas A Keks, Judy Hope, Darren Schwartz, et al.
CNS Drugs (2020) Vol. 34, Iss. 5, pp. 473-507
Closed Access | Times Cited: 51
Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis
Zhenyu Zhu, Yuxiu Gu, Cuirong Zeng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Zhenyu Zhu, Yuxiu Gu, Cuirong Zeng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Understanding the Effects of Antipsychotics on Appetite Control
Sayani Mukherjee, Silje Skrede, Edward Milbank, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 35
Sayani Mukherjee, Silje Skrede, Edward Milbank, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 35
Drug-induced mitochondrial toxicity: Risks of developing glucose handling impairments
Auxiliare Kuretu, Charles Arineitwe, Mamosheledi Mothibe, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 19
Auxiliare Kuretu, Charles Arineitwe, Mamosheledi Mothibe, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 19
Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia
Wade Marteene, Karl Winckel, Samantha Hollingworth, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 12, pp. 1149-1160
Open Access | Times Cited: 47
Wade Marteene, Karl Winckel, Samantha Hollingworth, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 12, pp. 1149-1160
Open Access | Times Cited: 47
Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia
Steven G. Potkin, Jelena Kunovac, Bernard L. Silverman, et al.
The Journal of Clinical Psychiatry (2020) Vol. 81, Iss. 2
Open Access | Times Cited: 46
Steven G. Potkin, Jelena Kunovac, Bernard L. Silverman, et al.
The Journal of Clinical Psychiatry (2020) Vol. 81, Iss. 2
Open Access | Times Cited: 46
Antipsychotics Promote Metabolic Disorders Disrupting Cellular Lipid Metabolism and Trafficking
Chiara Vantaggiato, Elena Panzeri, Andrea Citterio, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 3, pp. 189-210
Closed Access | Times Cited: 44
Chiara Vantaggiato, Elena Panzeri, Andrea Citterio, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 3, pp. 189-210
Closed Access | Times Cited: 44
The Benefits of Olanzapine in Palliating Symptoms
Mellar P. Davis, Gareth J. Sanger
Current Treatment Options in Oncology (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 43
Mellar P. Davis, Gareth J. Sanger
Current Treatment Options in Oncology (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 43
Hyperleptinemia contributes to antipsychotic drug–associated obesity and metabolic disorders
Shangang Zhao, Qian Lin, Wei Xiong, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 723
Open Access | Times Cited: 15
Shangang Zhao, Qian Lin, Wei Xiong, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 723
Open Access | Times Cited: 15
Unraveling the serotonin saga: from discovery to weight regulation and beyond - a comprehensive scientific review
Kristie Conde, Shuzheng Fang, Yong Xu
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Kristie Conde, Shuzheng Fang, Yong Xu
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Obesity exacerbates the acute metabolic side effects of olanzapine
Logan K. Townsend, Willem T. Peppler, Natasha Bush, et al.
Psychoneuroendocrinology (2017) Vol. 88, pp. 121-128
Closed Access | Times Cited: 46
Logan K. Townsend, Willem T. Peppler, Natasha Bush, et al.
Psychoneuroendocrinology (2017) Vol. 88, pp. 121-128
Closed Access | Times Cited: 46
Preclinical and Clinical Sex Differences in Antipsychotic-Induced Metabolic Disturbances: A Narrative Review of Adiposity and Glucose Metabolism
L Castellani, Kenya A. Costa-Dookhan, William Brett McIntyre, et al.
Journal of Psychiatry and Brain Science (2019)
Open Access | Times Cited: 41
L Castellani, Kenya A. Costa-Dookhan, William Brett McIntyre, et al.
Journal of Psychiatry and Brain Science (2019)
Open Access | Times Cited: 41
Olanzapine exposure disordered lipid metabolism, gut microbiota and behavior in zebrafish (Danio rerio)
Yawei Wang, Fu You, Zhenyi Huang, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2025) Vol. 289, pp. 110120-110120
Closed Access
Yawei Wang, Fu You, Zhenyi Huang, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2025) Vol. 289, pp. 110120-110120
Closed Access
Clinical Characterisation of the Co-Occurrence of Mental and Physical Disorders
R. I. G. Holt
(2025), pp. 127-160
Closed Access
R. I. G. Holt
(2025), pp. 127-160
Closed Access
